1 / 1
Pirtobrutinib(Jaypirca)
Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection
Reference price:
Manufacturer:
Eli Lilly and Company
Formulation:
TABLET
Validity period:
24 months
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of
a
pharmacist. For read by medical and pharmaceutical professionals only.
Jaypirca(Pirtobrutinib) Instructions:Uses,Dosage, Side Effects
JAYPIRCA, with the generic name pirtobrutinib, is an orally administered kinase inhibitor. Its active pharmaceutical ingredient targets Bruton's tyrosine kinase (BTK), including both wild-type and C481-mutated forms. It is formulated as film-coated tablets designed for oral ingestion, functioning as a small molecule, noncovalent BTK inhibitor that modulates B-cell receptor signaling pathways crucial for B-cell proliferation and survival.
